cagrilintide results In the REDEFINE 2 phase 3a trial involving adults with obesity and diabetes, the use of cagrilintide–semaglutide resulted in a significantly lower body weight than placebo at 68 weeks. Full trial Amylin Injectable Cagrilintide Demonstrates Weight

BPC-157: Derived from a protein found in gastric juice, BPC-157 promotes healing by enhancing blood flow and reducing inflammation

342 In another randomized controlled trial, 29 healthy individuals with anxious personalities were treated with 3 grams each of L-lysine and L-arginine for 10 days, and then exposed to a social stressor

20 mg Vial Protocol (3 mL = 6.67 mg/mL) Weeks 14250 mcg (0.25 mg)4 units (0.04 mL) Weeks 58500 mcg (0.5 mg)7.5 units (0.075 mL) Weeks 9121000 mcg (1.0 mg)15 units (0.15 mL) Weeks 13161700 mcg (1.7 mg)25.5 units (0.255 mL) Weeks 17+ (Maintenance)2400 mcg (2.4 mg)36 units (0.36 mL) Reconstitution: Add 3.0 mL bacteriostatic water 6.67 mg/mL concentration

Morgan SJ, McKenna P, Bosanquet RC

Squeeze firmly in order to remove as much moisture as possible

Bisphenol A (BPA) and phthalates, omnipresent in consumer products ranging from food packaging to personal care items, lead to widespread human exposure, with typical daily intake levels of 0.1-4 g/kg body weight for BPA and 1-20 g/kg body weight for phthalates